Press Releases About Continuing Research into New Drug Therapies for PNH
Posted on
Achillion slumps 33% on potential safety issue with PNH candidate ACH-4471 Read Here Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan Read Here Akari Therapeutics […]
Read more About Press Releases About Continuing Research into New Drug Therapies for PNH